{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:44:51Z","timestamp":1790081091460,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sk\u00e5ne Regional Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid-related mortality is high and increasing in the Western world, and interventions aimed at reducing opioid-related deaths represent an important area of study. In Sk\u00e5ne County, Sweden, a patient choice reform resulted in increased access to opioid substitution treatment (OST). In addition, a gradual shift towards less restrictive terms for exclusion from OST has been implemented. The aim of this study was to assess the impact of these policy changes on opioid-related deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Detailed data on opioid-related deaths in Sk\u00e5ne during the 2\u00a0years prior to and following the policy change were obtained from forensic records and from health care services. Data on overdose deaths for Sk\u00e5ne and the rest of Sweden were obtained using publicly available national register data. Time periods were used as the predictor for opioid-related deaths in the forensic data. The national level data were used in a natural experiment design in which rates of overdose deaths were compared between Sk\u00e5ne and the rest of Sweden before and after the intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was no significant difference in the number of deaths in Sk\u00e5ne between the data collection periods (RR: 1.18 95% CI:0.89\u20131.57,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.251). The proportion of deaths among patients enrolled in OST increased between the two periods (2.61, 1.12\u20136.10,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.026). There was no change in deaths related to methadone or buprenorphine in relation to deaths due to the other opioids included in the study (0.92, 0.51\u20131.63,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.764). An analysis of national mortality data showed an annual relative decrease in unintentional drug deaths in Sk\u00e5ne compared to the rest of Sweden following the onset of the reform (0.90, 0.84\u20130,97,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Opioid-related deaths, as assessed using forensic data, has not changed significantly in Sk\u00e5ne following a change to lower-threshold OST. By contrast, national level data indicate that the policy change has been associated with decreased overdose deaths. The discrepancy between these results highlights the need for more research to elucidate this issue. The result that more patients die during ongoing OST following an increase in access to treatment underlines the need for further preventive interventions within the OST treatment setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-021-00351-4","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T02:37:45Z","timestamp":1613011065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Changes in opioid-related deaths following increased access to opioid substitution treatment"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-2482","authenticated-orcid":false,"given":"Lisa","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"9","key":"351_CR1","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/add.12598","volume":"109","author":"T Gomes","year":"2014","unstructured":"Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. The burden of premature opioid-related mortality. Addiction. 2014;109(9):1482\u20138.","journal-title":"Addiction"},{"key":"351_CR2","volume-title":"European Drug Report 2018: Trends and developments. European Monitoring Centre for Drugs and Drug Addiction","author":"EMCDDA","year":"2018","unstructured":"EMCDDA. European Drug Report 2018: Trends and developments. European Monitoring Centre for Drugs and Drug Addiction. Lisbon: EMCDDA; 2018."},{"issue":"1_suppl","key":"351_CR3","doi-asserted-by":"publisher","first-page":"24S","DOI":"10.1177\/0033354918793627","volume":"133","author":"B Saloner","year":"2018","unstructured":"Saloner B, EE MG, Beletsky L, Bluthenthal R, Beyrer C, Botticelli M, et al. A public health strategy for the opioid crisis. Public Health Rep. 2018;133(1_suppl):24S\u201334S.","journal-title":"Public Health Rep"},{"issue":"4","key":"351_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jsr.2012.08.009","volume":"43","author":"LJ Paulozzi","year":"2012","unstructured":"Paulozzi LJ. Prescription drug overdoses: A review. J Saf Res. 2012;43(4):283\u20139.","journal-title":"J Saf Res."},{"issue":"10208","key":"351_CR5","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, BDL M, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560\u201379.","journal-title":"Lancet"},{"key":"351_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559\u201374.","journal-title":"Annu Rev Public Health"},{"key":"351_CR7","volume-title":"[The National Board of Health and Welfare]. Statistics on causes of death","author":"Socialstyrelsen","year":"2019","unstructured":"Socialstyrelsen. [The National Board of Health and Welfare]. Statistics on causes of death. Stockholm: Socialstyrelsen; 2019. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/statistics\/"},{"key":"351_CR8","volume-title":"Drug-related deaths in Sweden- Estimations of trends, effects of changes in recording practices and studies of drug patterns. Centralf\u00f6rbundet f\u00f6r alkohol- och narkotikaupplysning. [The Swedish Council for Information on Alcohol and Other Drugs]","author":"H Leifman","year":"2016","unstructured":"Leifman H. Drug-related deaths in Sweden- Estimations of trends, effects of changes in recording practices and studies of drug patterns. Centralf\u00f6rbundet f\u00f6r alkohol- och narkotikaupplysning. [The Swedish Council for Information on Alcohol and Other Drugs]. Stockholm: CAN; 2016."},{"key":"351_CR9","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. CochraneDatabase of Syst Rev. 2009;Issue 3. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2. Accessed 31 Jan 2021.","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"1","key":"351_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351.","journal-title":"Addiction"},{"key":"351_CR11","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"351_CR12","doi-asserted-by":"crossref","unstructured":"Steer CD, Macleod J, Tilling K, Lim AG, Marsden J, Millar T, et al. The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study. Heal Serv Deliv Res. 2019;7(3).","DOI":"10.3310\/hsdr07030"},{"issue":"2","key":"351_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/v10199-012-0012-0","volume":"29","author":"B Svensson","year":"2012","unstructured":"Svensson B, Andersson M. Involuntary discharge from medication-assisted treatment for people with heroin addiction-patients\u2019 experiences and interpretations. Nord Stud Alcohol Drugs. 2012;29(2):173\u201393.","journal-title":"Nord Stud Alcohol Drugs"},{"key":"351_CR14","volume-title":"Alkohol-och narkotikaproblem. [Alcohol and other drug problems]","author":"B Johnson","year":"2017","unstructured":"Johnson B, Richert T, Svensson B. Alkohol-och narkotikaproblem. [Alcohol and other drug problems]. Lund: Studentlitteratur; 2017."},{"key":"351_CR15","volume-title":"En dyster parentes : opiatregeln i svensk LARO-behandling 2010\u20132016. [A dismal parenthesis: The opiate rule in Swedish opioid maintenance treatment 2010\u20132016]","author":"B Monwell","year":"2019","unstructured":"Monwell B. En dyster parentes : opiatregeln i svensk LARO-behandling 2010\u20132016. [A dismal parenthesis: The opiate rule in Swedish opioid maintenance treatment 2010\u20132016]. J\u00f6nk\u00f6ping: J\u00f6nk\u00f6ping University; 2019. Available from: http:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:hj:diva-43443"},{"issue":"2","key":"351_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/09687637.2019.1591342","volume":"27","author":"L Andersson","year":"2020","unstructured":"Andersson L, Johnson B. Patient choice as a means of empowerment in opioid substitution treatment: a case from Sweden. Drugs Educ Prev Policy. 2020;27(2):105\u201317.","journal-title":"Drugs Educ Prev Policy."},{"key":"351_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2016.12.005","volume":"74","author":"A Ledberg","year":"2017","unstructured":"Ledberg A. Mortality related to methadone maintenance treatment inStockholm, Sweden, during 2006\u20132013. J Subst Abuse Treat. 2017;74:35\u201341 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216304123.","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"351_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/j.1360-0443.2010.02999.x","volume":"105","author":"A Romelsj\u00f6","year":"2010","unstructured":"Romelsj\u00f6 A, Engdahl B, Stenbacka M, Fugelstad A, Davstad I, Leifman A, et al. Were the changes to Sweden\u2019s maintenance treatment policy 2000\u201306 related to changes in opiate-related mortality and morbidity? Addiction. 2010;105(9):1625\u201332.","journal-title":"Addiction."},{"key":"351_CR19","doi-asserted-by":"publisher","DOI":"10.24834\/2043\/25469","volume-title":"Valfrihet och egenmakt : en utv\u00e4rdering av Region Sk\u00e5nes v\u00e5rdval f\u00f6r LARO. [Freedom of choice: An evaluation of patient choice in opioid substitution treatment in Region Sk\u00e5ne]","author":"L Andersson","year":"2018","unstructured":"Andersson L, Johnson B. Valfrihet och egenmakt : en utv\u00e4rdering av Region Sk\u00e5nes v\u00e5rdval f\u00f6r LARO. [Freedom of choice: An evaluation of patient choice in opioid substitution treatment in Region Sk\u00e5ne]. Malm\u00f6: Malm\u00f6 universitet; 2018."},{"key":"351_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","volume":"161","author":"G Kourounis","year":"2016","unstructured":"Kourounis G, BDW R, Kyprianou E, Symeonidou E, Malliori M-M, Samartzis L, et al. Drug Alcohol Depend. 2016;161:1\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"351_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000097935","volume":"13","author":"H Waal","year":"2007","unstructured":"Waal H. Merits and problems in high-threshold methadone maintenance treatment. Eur Addict Res. 2007;13(2):66\u201373.","journal-title":"Eur Addict Res"},{"issue":"5","key":"351_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/16066359.2010.545158","volume":"19","author":"M Ekendahl","year":"2011","unstructured":"Ekendahl M. The limits of legitimacy: service providers\u2019 views on maintenance treatment in Sweden. Addict Res Theory. 2011;19(5):427\u201337.","journal-title":"Addict Res Theory"},{"key":"351_CR23","unstructured":"Johnson B. After the storm. Developments in maintenance treatment policy and practice in Sweden 1987\u20132006. In: On the margins Nordic alcohol and drug treatment 1885\u20132007. Helsinki: Nordic Centre for Alcohol and Drug Research; 2007."},{"key":"351_CR24","volume-title":"[The National Board of Health and Welfare]. Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d (HSLF-FS 2016:1) om l\u00e4kemedelsassisterad behandling vid opioidberoende [Code of statutes (HSLF-FS 2016:1) regulating opioid substitution treatment]","author":"Socialstyrelsen","year":"2016","unstructured":"Socialstyrelsen. [The National Board of Health and Welfare]. Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d (HSLF-FS 2016:1) om l\u00e4kemedelsassisterad behandling vid opioidberoende [Code of statutes (HSLF-FS 2016:1) regulating opioid substitution treatment]. Stockholm: Socialstyrelsen; 2016."},{"issue":"7","key":"351_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, De La Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100(7):981\u20139.","journal-title":"Addiction"},{"key":"351_CR26","first-page":"39","volume":"10","author":"T Clausen","year":"2014","unstructured":"Clausen T. The Norwegian OMT program-benefits and challenges. Nor J Pharm. 2014;10:39\u201342.","journal-title":"Nor J Pharm"},{"issue":"18","key":"351_CR27","first-page":"1225","volume":"107","author":"A Fugelstad","year":"2010","unstructured":"Fugelstad A, Johansson LA, Thiblin I. Allt fler d\u00f6r av metadon. [More and more people die from methadone]. L\u00e4kartidningen. 2010;107(18):1225\u20138.","journal-title":"L\u00e4kartidningen"},{"key":"351_CR28","doi-asserted-by":"publisher","first-page":"c4851","DOI":"10.1136\/bmj.c4851","volume":"341","author":"J Strang","year":"2010","unstructured":"Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993\u20132008): analyses using OD4 index in England and Scotland. BMJ. 2010;341:c4851.","journal-title":"BMJ"},{"issue":"4","key":"351_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.amepre.2010.05.016","volume":"39","author":"E Piercefield","year":"2010","unstructured":"Piercefield E, Archer P, Kemp P, Mallonee S. Increase in unintentional medication overdose deaths: Oklahoma, 1994\u20132006. Am J Prev Med. 2010;39(4):357\u201363.","journal-title":"Am J Prev Med"},{"issue":"5","key":"351_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000446429","volume":"22","author":"C Tjagvad","year":"2016","unstructured":"Tjagvad C, Skurtveit S, Linnet K, Andersen LV, Christoffersen DJ, Clausen T. Methadone-related overdose deaths in a liberal opioid maintenance treatment programme. Eur Addict Res. 2016;22(5):249\u201358.","journal-title":"Eur Addict Res"},{"issue":"1","key":"351_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1):8\u201318.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"351_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12954-015-0037-2","volume":"12","author":"T Richert","year":"2015","unstructured":"Richert T, Johnson B. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden. Harm Reduct J. 2015;12(1):12.","journal-title":"Harm Reduct J"},{"issue":"6","key":"351_CR33","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","volume":"24","author":"M Harris","year":"2013","unstructured":"Harris M, Rhodes T. Methadone diversion as a protective strategy: the harm reduction potential of \u2018generous constraints.\u2019. Int J Drug Policy. 2013;24(6):e43\u201350.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"351_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0354-y","volume":"17","author":"L Andersson","year":"2020","unstructured":"Andersson L, H\u00e5kansson A, Krantz P, Johnson B. Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances. Harm Reduct J. 2020;17(1):1\u201311.","journal-title":"Harm Reduct J"},{"issue":"5","key":"351_CR35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/add.13249","volume":"111","author":"M Br\u00e5b\u00e4ck","year":"2016","unstructured":"Br\u00e5b\u00e4ck M, Nilsson S, Isendahl P, Troberg K, Br\u00e5dvik L, H\u00e5kansson A. Malm\u00f6 Treatment Referral and Intervention Study (MATRIS)\u2014effective referral from syringe exchange to treatment for heroin dependence: a pilot randomized controlled trial. Addiction. 2016;111(5):866\u201373.","journal-title":"Addiction"},{"issue":"2\u20133","key":"351_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.forsciint.2006.08.002","volume":"169","author":"AK J\u00f6nsson","year":"2007","unstructured":"J\u00f6nsson AK, Holmgren P, Druid H, Ahlner J. Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002\u20132003. Forensic Sci Int. 2007;169(2\u20133):101\u20137.","journal-title":"Forensic Sci Int"},{"issue":"9","key":"351_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talb\u00e4ck M, H\u00f6rnblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765\u201373.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"351_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.forsciint.2007.09.012","volume":"176","author":"P Bendroth","year":"2008","unstructured":"Bendroth P, Kronstrand R, Helander A, Greby J, Stephanson N, Krantz P. Comparison of ethyl glucuronide in hair with phosphatidylethanol in whole blood as post-mortem markers of alcohol abuse. Forensic Sci Int. 2008;176(1):76\u201381.","journal-title":"Forensic Sci Int"},{"issue":"1","key":"351_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1520\/JFS14071J","volume":"42","author":"H Druid","year":"1997","unstructured":"Druid H, Holmgren P. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci. 1997;42(1):79\u201387.","journal-title":"J Forensic Sci"},{"issue":"5","key":"351_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/dar.12143","volume":"33","author":"BN Wikner","year":"2014","unstructured":"Wikner BN, \u00d6hman I, Seld\u00e9n T, Druid H, Brandt L, Kieler H. Opioid-related mortality and filled prescriptions for buprenorphine and methadone. Drug Alcohol Rev. 2014;33(5):491\u20138.","journal-title":"Drug Alcohol Rev"},{"key":"351_CR41","unstructured":"Statistics Sweden. Available from: https:\/\/www.scb.se\/en\/finding-statistics\/statistics-by-subject-area\/population\/ Accessed 10 Apr 2020."},{"key":"351_CR42","volume-title":"[The National Board of Health and Welfare]. Kartl\u00e4ggning av l\u00e4kemedelsassisterad behandling vid opiatberoende. [Mapping of opiate substitution treatment]","author":"Socialstyrelsen","year":"2012","unstructured":"Socialstyrelsen. [The National Board of Health and Welfare]. Kartl\u00e4ggning av l\u00e4kemedelsassisterad behandling vid opiatberoende. [Mapping of opiate substitution treatment]. Stockholm: Socialstyrelsen; 2012."},{"key":"351_CR43","unstructured":"KEFU. V\u00e5rdvalets och ers\u00e4ttningsmodellens effekter f\u00f6r L\u00e4kemedelsassisterad rehabilitering vid opiatberoende (LARO). [The effects of the patient choice and the compensation model on opioid substitution treatment]. KEFU \u2013 R\u00e5det f\u00f6r kommunalekonomisk forskning och utbildning. [The council for municipal economical research and education]. Lund: KEFU; 2015."},{"key":"351_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-77318-6","volume-title":"Applied econometrics with R","author":"C Kleiber","year":"2008","unstructured":"Kleiber C, Zeileis A. Applied econometrics with R. New York: Springer Science & Business Media; 2008."},{"key":"351_CR45","unstructured":"Region Sk\u00e5ne. Utredning om v\u00e5rdval. L\u00e4kemedelsassisterad Rehabilitering vid Opiatberoende, LARO. [An inquiry into patient choice reforms. Opiate substitution treatment, OST]. Malm\u00f6: Region Sk\u00e5ne; 2013."},{"issue":"1","key":"351_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/08897077.2015.1065541","volume":"37","author":"T Abrahamsson","year":"2016","unstructured":"Abrahamsson T, Widinghoff C, Lilliebladh A, Gedeon C, Nilvall K, Hakansson A. Interim buprenorphine treatment in opiate dependence: a pilot effectiveness study. Subst Abus. 2016;37(1):104\u20139.","journal-title":"Subst Abus"},{"issue":"5","key":"351_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","volume":"164","author":"J Kakko","year":"2007","unstructured":"Kakko J, Gr\u00f6nbladh L, Svanborg KD, von Wachenfeldt J, R\u00fcck C, Rawlings B, et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 2007;164(5):797\u2013803.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"351_CR48","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.2105\/AJPH.2013.301709","volume":"104","author":"KM Keyes","year":"2014","unstructured":"Keyes KM, Cerd\u00e1 M, Brady JE, Havens JR, Galea S. Understanding the rural\u2013urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):e52\u20139.","journal-title":"Am J Public Health"},{"issue":"3","key":"351_CR49","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/ruso.12307","volume":"85","author":"DJ Peters","year":"2020","unstructured":"Peters DJ, Monnat SM, Hochstetler AL, Berg MT. The opioid hydra: Understanding overdose mortality epidemics and syndemics across the rural-urbancontinuum. Rural Sociol. 2020;85(3):589\u2013622.","journal-title":"Rural Sociol."},{"key":"351_CR50","volume-title":"Drogutvecklingen i Sverige 2019 - med fokus p\u00e5 narkotika. [Drug development in Sweden 2019 - with a focus on illicit drugs]","author":"CAN","year":"2019","unstructured":"CAN. Drogutvecklingen i Sverige 2019 - med fokus p\u00e5 narkotika. [Drug development in Sweden 2019 - with a focus on illicit drugs]. Stockholm: Centralf\u00f6rbundet f\u00f6r alkohol- och narkotikaupplysning; 2019. [The Swedish Council for Information on Alcohol and Other Drugs] Available from: https:\/\/www.can.se\/app\/uploads\/2020\/01\/can-rapport-180-drogutvecklingen-i-sverige-2019.pdf"},{"issue":"1","key":"351_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.forsciint.2012.11.010","volume":"224","author":"J-P Bernard","year":"2013","unstructured":"Bernard J-P, Havnes I, Sl\u00f8rdal L, Waal H, M\u00f8rland J, Khiabani HZ. Methadone-related deaths in Norway. Forensic Sci Int. 2013;224(1):111\u20136.","journal-title":"Forensic Sci Int"},{"issue":"4","key":"351_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/PAF.0b013e3181ca4b1e","volume":"31","author":"C Albion","year":"2010","unstructured":"Albion C, Shkrum M, Cairns J. Contributing factors to methadone-related deaths in Ontario. Am J Forensic Med Pathol. 2010;31(4):313\u20139.","journal-title":"Am J Forensic Med Pathol"},{"key":"351_CR53","doi-asserted-by":"publisher","DOI":"10.1787\/a18286f0-en","volume-title":"Addressing Problematic Opioid Use in OECD countries. OECD Health Policy Studies","author":"OECD","year":"2019","unstructured":"OECD. Addressing Problematic Opioid Use in OECD countries. OECD Health Policy Studies. Paris: OECD Publishing; 2019. https:\/\/doi.org\/10.1787\/a18286f0-en."},{"key":"351_CR54","volume-title":"European Drug Report 2017: Trends and developments. European Monitoring Centre for Drugs and Drug Addiction","author":"EMCDDA","year":"2017","unstructured":"EMCDDA. European Drug Report 2017: Trends and developments. European Monitoring Centre for Drugs and Drug Addiction. Lisbon: EMCDDA; 2017."},{"key":"351_CR55","doi-asserted-by":"crossref","unstructured":"Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018;361(6408):eaau1184.","DOI":"10.1126\/science.aau1184"},{"issue":"11","key":"351_CR56","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1503\/cmaj.060729","volume":"175","author":"B Fischer","year":"2006","unstructured":"Fischer B, Rehm J, Patra J, Cruz MF. Changes in illicit opioid use across Canada. CMAJ. 2006;175(11):1385.","journal-title":"CMAJ"},{"key":"351_CR57","doi-asserted-by":"publisher","unstructured":"Fugelstad A, Bremberg S, Hjelmstr\u00f6m P, Thiblin I. Methadone-related deaths among youth and young adults in Sweden 2006\u20132015. Addiction. 2020. https:\/\/doi.org\/10.1111\/add.15152 Online ahead of print.","DOI":"10.1111\/add.15152"},{"key":"351_CR58","doi-asserted-by":"publisher","unstructured":"Mariottini C, Kriikku P, Ojanper\u00e4 I. Concomitant drugs with buprenorphine user deaths. Drug Alcohol Depend. 2020. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108345 Online ahead of print.","DOI":"10.1016\/j.drugalcdep.2020.108345"},{"key":"351_CR59","doi-asserted-by":"publisher","unstructured":"Bech AB, Clausen T, Waal H, Vindenes V, Edvardsen HE, Frost J, Skeie I.). Postmortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrations. Addiction. 2020; doi: https:\/\/doi.org\/10.1111\/add.15211 Online ahead of print.","DOI":"10.1111\/add.15211"},{"issue":"1\u20133","key":"351_CR60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","volume":"94","author":"T Clausen","year":"2008","unstructured":"Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008;94(1\u20133):151\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"351_CR61","unstructured":"Socialstyrelsen. [The National Board of Health and Welfare]. Narkotikarelaterade d\u00f6dsfall. En analys av 2014 \u00e5rs d\u00f6dsfall och utveckling av den officiella statistiken [Drug-related deaths. An analysis of the deaths in 2014 and trends in the official statistics]. Stockholm: Socialstyrelsen; 2016."}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13011-021-00351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T02:43:16Z","timestamp":1613011396000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00351-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-96764\/v1","asserted-by":"object"}]},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"26 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been subjected to ethical review and was approved by the Regional Ethical Review Board in Lund (case no. 2014\/547; 2015\/369 and 2016\/771).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LA, JB and BJ declare that they have no competing interests.AH holds a position at Lund University which is sponsored by the Swedish state-owned gambling operator AB Svenska Spel. He also disposes research grants from the research councils of AB Svenska Spel, the state-owned alcohol monopoly Systembolaget, and from the research council of the Swedish Enforcement Agency and the Swedish Sports Federation. He is involved in a clinical research study receiving non-financial support from the commercial body Kontigo Care in the area of digital follow-up tools in the treatment of addictive disorders. He is also the national principal investigator of a prior pharmaco-epidemiological survey study conducted by the US research institute Research Triangle Institute and sponsored by the pharmaceutical company Shire, which supported the conduct of the study but did not provide personal fees to the individual researcher. The present competing interests are not involved in \u2013 and did not have any influence on \u2013 the present research project.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}